期刊文献+

IL-6、IL-18和IFN-γ在特发性血小板减少性紫癜中的水平变化 被引量:2

Changes of serum IL-6, IL-18 and IFN-γ in children with idiopathic thrombocytopenic purura
原文传递
导出
摘要 目的通过测定特发性血小板减少性紫癜(ITP)患儿血清中白细胞介素-6(IL-6)、白细胞介素-18(IL-18)和γ-干扰素(IFN-γ)的含量变化,探讨IL-6、IL-18和IFN-γ在ITP的发病机制中的作用。方法选择ITP急性发作期患儿40例(急性组),经治疗后处于缓解期的患儿35例(缓解组),另选择30名健康儿童作为对照(对照组),采用酶联免疫法(ELISA)检测血清IL-6、IL-18和IFN-γ水平变化,并进行统计学分析比较。结果ITP患儿血清IL-6、IL-18和IFN一叮水平急性期组明显高于缓解期组和对照组,缓解期组亦高于对照组,差异均有统计学意义(P均〈0.05)。结论IL-6、IL-18和IFN-γ可能均参与了ITP的发病机制,通过测定血清IL-6、IL-18和IFN-γ水平可以用来判断ITP的病情和预后。 Objective To study the content changes of serum IL-6, IL-18 and IFN-γin childrenwith idiopathic thrombocytopenic (ITP), and to investigate the role pathogenesis of IL-6, IL-18 and IFN-γMethods Active group (n = 40)and remission group (n = 35 )with ITR were picked up, and 30 healthy children served as normal controls. IL-6, IL-18 and IFN-γlevels were measured by ELISA, and the results were compared. Results The serum levels of IL-6, IL-18 and IFN-γ in children with active group were markedly higher than those in remission group and healthy controls, and the serum levels of IL-6, IL-18 and IFN-γin remission group were markedly higher than those in healthy controls (P 〈 0. 05). Conclu- sions IL-6, IL-18 and IFN-γmaybe involved in the pathogenesis of ITP. Determination of IL-6, IL-18 and INF-γlevels can be used to judge the ITP' s condition and prognosis.
作者 路桂云
出处 《中国实用医刊》 2013年第15期54-56,共3页 Chinese Journal of Practical Medicine
关键词 特发性血小板减少性紫癜 白细胞介素-6 白细胞介素-18 Γ-干扰素 Idiopathic thrombocytopenic purpura Interleukin-6 Interleukin-18 Interferon-γ
  • 相关文献

参考文献10

二级参考文献43

  • 1McFarland J. Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura [ J ]. Blood Rev, 2002,16 (1):1-2.
  • 2Cines DB, Blanchette VS. Immue thrombocytopenic purpura[ J]. N Engl J Med,2002,346(13) :995-1008.
  • 3Ikebuchi K, Wong GG, Clark SC, et al. Interleukin 6 enhancement of interleukin 3-dependent proliferation of muhipotential hemopoietic progenitors [J]. Proc Natl Acarl Sci USA, 1987,84 (24) :9035-9039.
  • 4Lin JX, Leonard WJ. The role of StatSa and StatSb in signaling by IL-2 family cytokine [ J ]. Oncogene ,2000,19 ( 21 ) :2566-2576.
  • 5Benda B, Korsgren O. Signaling domains of the interleukin 2 receptor[J]. Cytokine, 2001,14(2) : 63-71.
  • 6Araki K, Harada K, Nakamoto K, et al. Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers [ J]. Clin Exp Immunol,2000,119 (2) :259-263.
  • 7Wahl P, Schoop R, Horan TP, et al. Interaction of BTRP-1 with ICOS negatively regulates antigen presentation by B cells. Inflammation, 2003, 27: 191-200.
  • 8Freeman GL, Long AJ, Iwai Y, et al. Engagement of the PD-1immnoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med, 2000,192:1027-1034.
  • 9Loke P, Allison J. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proc Natl Acad Sci U S A, 2003, 100: 5336-5341.
  • 10Glimcher LH, Murphy KM. Lineage commitment in the immune system: the T helper lymphocyte grows up. Gene Dev, 2000, 14:1693-1711.

共引文献2432

同被引文献18

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部